Abstract-Radio Frequency Identification (RFID) technology allows automatic data capture from tagged objects moving in a supply chain. This data can be very useful if it is used to answer traceability queries, however it is distributed across many different repositories, owned by different companies.Discovery Services (DS) are designed to assist in retrieving the RFID data relevant for traceability queries while enforcing sharing policies that are defined and required by participating companies to prevent sensitive data from being exposed.In this paper we define an interface for Supply Chain Authorization (SC-Az) and describe the implementation of two visibility restriction mechanisms based on Access Control Lists (ACLs) and Capabilities. Both approaches were converted to the standard eXtensible Access Control Markup Language (XACML) and their correctness and performance was evaluated for supply chains with increasing size.
The Pharma(ceuticals) industry is at a cross-roads. There are growing concerns that illegitimate products are penetrating the supply chain. There are proposals in many countries to apply RFID and other traceability technologies to solve this problem. However there are several trade-offs and one of the most crucial is between data visibility and confidentiality.In this paper, we use the TrakChain assessment framework tools to study the US Pharma supply chain and to compare candidate solutions to achieve traceability data security: Point-ofDispense Authentication, Network-based electronic Pedigree, and Document-based electronic Pedigree. We also propose extensions to a supply chain authorization language that is able to capture expressive data sharing conditions considered necessary by the industry's trading partners.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.